Publications by authors named "C Schmid-Tannwald"

Article Synopsis
  • The study investigates the factors influencing the need for permanent pacemaker (PPM) implantation after transcatheter aortic valve replacement (TAVR), a common complication following the procedure.
  • Researchers analyzed data from 2105 TAVR patients, excluding those with specific complications, to identify predictive models for PPM necessity.
  • Key findings indicate that clinical and ECG factors (like right bundle branch block) are stronger predictors of PPM implantation compared to imaging parameters, with a scaled LASSO model achieving an AUC of 0.70.
View Article and Find Full Text PDF

: A debate persists on the prognostic value of the pre-therapeutic standardized uptake value (SUV) of non-tumorous lung tissue for the risk assessment of therapy-related pneumonitis, with most studies lacking significant correlation. However, the influence of patient comorbidities on the pre-therapeutic lung SUV has not yet been systematically evaluated. Thus, we aimed to elucidate the association between comorbidities, biological variables and lung SUVs in pre-therapeutic [F]FDG-PET/CT.

View Article and Find Full Text PDF

Background: The study aimed to compare and correlate morphological and functional parameters in pancreatic neuroendocrine tumors (pNET) and their synchronous liver metastases (NELM), while also assessing prognostic imaging parameters.

Methods: Patients with G1/G2 pNET and synchronous NELM underwent pretherapeutic abdominal MRI with DWI and 68Ga-DOTATATE/TOC PET/CT were included. ADC (mean, min), SNR_art and SNT_T2 (SNR on arterial phase and on T2) and SUV (max, mean) for three target NELM and pNET, as well as tumor-free liver and spleen (only in PET/CT) were measured.

View Article and Find Full Text PDF
Article Synopsis
  • This study looked at how special scans (Ga-DOTA-TATE PET/CT) can help predict how well a cancer treatment called everolimus works for patients with neuroendocrine tumors that have spread to the liver.
  • Researchers checked the size and activity of tumors before and after treatment in 29 patients to see if they were getting better.
  • They found that certain measurements from the scans could help figure out which patients would have a longer time without the disease getting worse, showing that these scans are important for monitoring treatment.
View Article and Find Full Text PDF

Background: Neuroendocrine tumors of the pancreas have a broad biological spectrum. The treatment decision is based on an optimal diagnosis with regard to the local findings and possible locoregional and distant metastases. In addition to purely morphologic imaging procedures, functional parameters are playing an increasingly important role in imaging.

View Article and Find Full Text PDF